Columnist Ben Hofmeister has just completed his third overnight sleep study in three years as part of an effort to control sleep apnea.

People with MS who engage in more physical activity tend to have less severe physical and cognitive disability, a study demonstrated.

New clinical trial data suggest vidofludimus calcium can target key mechanisms underlying progressive multiple sclerosis.

MS pain is the uninvited guest you can't turn away, columnist Desiree Lama writes. Listening to your body is the key to ...

Bazedoxifene, a drug that alters the activity of the sex hormone estrogen, failed to promote myelin repair in women with MS, ...

Tolebrutinib failed to lower disability progression risk in primary progressive MS in a Phase 3 trial, with data shown at ...

In people with early MS, diet may correlate with biological aging and the development of disease-related disability, study ...

Presentation raises questions about EBV timing. Dalia Rotstein, MD, of the University of Toronto, discussed the findings and their implications in an oral presentation at the Amer ...

In a study, blocking the immune system complement protein C3 was shown to reduce MS disease severity in older mice but not in ...

Scientists at the 2026 ACTRIMS forum meet to assess current approaches and explore new directions for MS research and care.

The investigational therapy fenebrutinib was as effective as Ocrevus for reducing disability progression in people with PPMS, ...

Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...